Xia M-F, Ling Y, Bian H, Lin H-D, Yan H-M, Chang X-X, Li X-M, Ma H, Wang D, Zhang L-S, Wang S-S, Wu B-J, He W-Y, Zhao N-Q, Gao X
Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China.
Institute of Chronic Metabolic Diseases, Fudan University, Shanghai, China.
Aliment Pharmacol Ther. 2016 Mar;43(5):631-42. doi: 10.1111/apt.13521. Epub 2016 Jan 13.
The patatin-like phospholipase 3 (PNPLA3) rs738409 gene polymorphism is an important genetic determinant of non-alcoholic fatty liver disease (NAFLD). However, the associations between liver fat and metabolic traits in rs738409 G allele carriers and the allelic influence on this association have not been fully studied.
To investigate the influence of the PNPLA3 gene polymorphism on the association of liver fat with serum metabolic factors and carotid atherosclerosis.
Liver fat was measured by quantitative ultrasound in 4300 subjects in the Shanghai Changfeng community and analysed for its association with obesity and metabolic factors in individuals with the PNPLA3 CC, CG and GG genotypes.
Non-alcoholic fatty liver disease occurred in 37.9% and 28.8% of the subjects with the GG and CC genotypes respectively (P < 0.001). Liver fat was significantly associated with body mass index, waist circumference, serum triglycerides, high-density lipoprotein cholesterol, fasting blood glucose and insulin in the PNPLA3 rs738409 G allele carriers (P < 0.001). Compared with the CC homozygotes, the GG homozygotes presented higher liver fat and liver fibrosis scores despite their better metabolic status (comparison of regression line slopes, P < 0.05). An increase in liver fat was accompanied by a significant increase in the average and maximum carotid intima-media thickness in subjects with the PNPLA3 CC genotype but not in those with the GG genotype.
PNPLA3 rs738409 G allele carriers were found to be more susceptible to the metabolic-related hepatic steatosis, and developed NAFLD and liver fibrosis despite presenting relatively better metabolic statuses and lower risks for carotid atherosclerosis.
帕他atin样磷脂酶3(PNPLA3)rs738409基因多态性是非酒精性脂肪性肝病(NAFLD)的重要遗传决定因素。然而,rs738409 G等位基因携带者的肝脏脂肪与代谢特征之间的关联以及该等位基因对这种关联的影响尚未得到充分研究。
探讨PNPLA3基因多态性对肝脏脂肪与血清代谢因子及颈动脉粥样硬化关联的影响。
采用定量超声测量上海长风社区4300名受试者的肝脏脂肪,并分析其与PNPLA3 CC、CG和GG基因型个体的肥胖及代谢因子的关联。
GG和CC基因型受试者中分别有37.9%和28.8%发生非酒精性脂肪性肝病(P<0.001)。在PNPLA3 rs738409 G等位基因携带者中,肝脏脂肪与体重指数、腰围、血清甘油三酯、高密度脂蛋白胆固醇、空腹血糖和胰岛素显著相关(P<0.001)。与CC纯合子相比,GG纯合子尽管代谢状态较好,但肝脏脂肪和肝纤维化评分更高(回归线斜率比较,P<0.05)。PNPLA3 CC基因型受试者肝脏脂肪增加伴随着颈动脉内膜中层平均厚度和最大厚度显著增加,而GG基因型受试者则不然。
发现PNPLA3 rs738409 G等位基因携带者更容易发生代谢相关的肝脂肪变性,尽管代谢状态相对较好且颈动脉粥样硬化风险较低,但仍会发展为NAFLD和肝纤维化。